DrugPatentWatch Database Preview
Novast Labs Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has fifty-eight approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Summary for Novast Labs
| US Patents: | 0 |
| Tradenames: | 56 |
| Ingredients: | 42 |
| NDAs: | 58 |
Drugs and US Patents for Novast Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novast Labs | LIDOCAINE | lidocaine | OINTMENT;TOPICAL | 208604-001 | Sep 20, 2017 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs Ltd | MONO-LINYAH | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 090523-001 | May 23, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs Ltd | ELINEST | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 091105-001 | Mar 28, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs | METOPROLOL SUCCINATE | metoprolol succinate | TABLET, EXTENDED RELEASE;ORAL | 204106-004 | Feb 6, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Novast Labs | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | CAPSULE;ORAL | 210267-001 | Mar 12, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
